Accessibility Menu
Arrow-Thin-Down
S&P 500
6,854.04
+0.1%
+7.43
Arrow-Thin-Down
DJI
48,305.55
+0.8%
+377.59
Arrow-Thin-Down
NASDAQ
23,402.75
-0.3%
-65.55
Arrow-Thin-Down
Bitcoin
$101,656.00
-1.4%
-$1,423.40
Arrow-Thin-Down
AAPL
$273.91
-0.5%
-$1.34
Arrow-Thin-Down
AMZN
$244.89
-1.7%
-$4.22
Arrow-Thin-Down
GOOG
$287.47
-1.5%
-$4.27
Arrow-Thin-Down
META
$610.24
-2.7%
-$16.84
Arrow-Thin-Down
MSFT
$511.18
+0.5%
+$2.50
Arrow-Thin-Down
NVDA
$192.84
-0.2%
-$0.32
Arrow-Thin-Down
TSLA
$432.17
-1.7%
-$7.45
Daily Stock GainersDaily Stock LosersMost Active Stocks
Invesco Exchange-Traded Fund Trust - Invesco Biotechnology & Genome ETF Stock Quote

Invesco Exchange-Traded Fund Trust - Invesco Biotechnology & Genome ETF (NYSEMKT: PBE)

$78.46
(0.6%)
+0.49
Price as of November 12, 2025, 3:19 p.m. ET

KEY DATA POINTS

Current Price
$78.46
Daily Change
(0.6%) +$0.49
Day's Range
$77.92 - $78.50
Previous Close
$77.97
Open
$77.92
Beta
0
Volume
3,522
Average Volume
-
Sector
Financials
Market Cap
0
Market Cap / Employee
-
52wk Range
$54.52 - $78.50
Revenue
-
Gross Margin
-
Dividend Yield
N/A
EPS
$0.00
CAPs Rating
-
Industry
Capital Markets

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Invesco Exchange-Traded Fund Trust - Invesco Biotechnology & Genome ETF Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
PBE+8.58%+27.11%+4.91%+450%
S&P+14.08%+93.57%+14.12%+470%

Invesco Exchange-Traded Fund Trust - Invesco Biotechnology & Genome ETF Company Info

The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the Dynamic Biotechnology & Genome IntellidexSM Index.

News & Analysis

Featured Article

Top ETFs Tracking CRISPR Gene Editing

These exchange-traded funds track companies in this biotech space.

Keith Speights  |  Oct 31, 2025
Featured Article

3 Ways You Can Be a Better Health-Care Investor Than Warren Buffett

Warren Buffett is a phenomenal investor -- but if you do these three things you could become a more successful health care investor than Buffett will ever be!

Sean Williams  |  Mar 9, 2014

Financial Health

General

No data available

No data available for this period.

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

No data available

No data available for this period.

Liabilities

No data available

No data available for this period.

Ratios

No data available

No data available for this period.

Cash Flow

No data available

No data available for this period.

Valuation

MetricYoY Change

No results found

No podcast episodes available.

No results found

No transcripts available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services